{
    "code": "52026253",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026253",
    "time": "2019-03-29 03:31:25",
    "許可證字號": "衛部藥輸字第026253號",
    "註銷狀態": "已註銷",
    "註銷日期": "107\/12\/03",
    "註銷理由": "自請註銷",
    "有效日期": "108\/02\/19",
    "發證日期": "103\/02\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA05202625305",
    "中文品名": "優游50優氟吸入劑",
    "英文品名": "Evoflo 50 Evohaler",
    "適應症": "EVOFLO適用於可逆性呼吸道阻塞疾病(ROAD)之常規治療，包括適合使用支氣管擴張劑及皮質類固醇組合療法的兒童與成人。這可能包括正在使用長效乙型作用劑(β-AGONIST)及吸入型皮質類固醇之有效維持劑量的患者。正在接受吸入型皮質類固醇療法，而仍有症狀之患者。接受支氣管擴張劑之常規治療，而需要吸入型皮質類固醇之患者。",
    "劑型": "103口腔吸入劑",
    "包裝": "60、120劑量金屬罐裝附吸入器",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "SALMETEROLXINAFOATEMICRONIZED,FLUTICASONEPROPIONATEMICRONIZED"
    ],
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "0901801100  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F150183000  GLAXO WELLCOME PRODUCTION",
        "製造廠廠址": "23 RUE LAVOISIER, ZONE INDUSTRIELLE NO.2, 27000 EVREUX, FRANCE",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1216002920",
            "成分名稱": "SALMETEROL XINAFOATE MICRONIZED",
            "含量描述": "(equivalent to 25mcg of Salmeterol)",
            "含量": "36.3000000000",
            "單位": "MCG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8406002220",
            "成分名稱": "FLUTICASONE PROPIONATE MICRONIZED",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MCG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020262530002-103-03-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026253&Seq=002&Type=9"
        },
        {
            "title": "020262530003-103-03-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026253&Seq=001&Type=8"
        }
    ]
}